<DOC>
	<DOCNO>NCT01102946</DOCNO>
	<brief_summary>The purpose study evaluate effect panretinal photocoagulation plus intravitreal ranibizumab treatment patient high risk proliferative diabetic retinopathy term change visual acuity neovascularization area .</brief_summary>
	<brief_title>Panretinal Photocoagulation ( PRP ) Plus Ranibizumab Proliferative Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Retinal Neovascularization</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Age ≥ 18 year old High risk proliferative diabetic retinopathy Visual acuity ≥ 20/800 No previous laser treatment diabetic retinopathy Previous par plana vitrectomy Systemic thromboembolic event Uncontrolled systemic hypertension Conditions avoid adequated documentation Previous eye surgery last 6 month inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>proliferative diabetic retinopathy</keyword>
	<keyword>retinal neovascularization</keyword>
	<keyword>Angiogenesis Inhibitors</keyword>
	<keyword>ranibizumab</keyword>
	<keyword>laser</keyword>
</DOC>